Publications by authors named "Miklos Pless"

61Publications

Inflammatory Myofibroblastic Tumor of the Bladder With FN1-ALK Gene Fusion: Different Response to ALK Inhibition.

Urology 2020 Sep 30. Epub 2020 Sep 30.

Department of Medical Oncology, Cantonal Hospital of Winterthur, Winterthur, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urology.2020.09.026DOI Listing
September 2020

Successful Treatment of a Resistant Subclone in ALK-Rearranged NSCLC.

Case Rep Oncol 2020 May-Aug;13(2):729-732. Epub 2020 Jun 26.

Department of Medical Oncology, Cantonal Hospital Winterthur, Winterthur, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000507850DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7383154PMC
June 2020

A Rare Differential Diagnosis of an Adrenal Mass: A Case Report.

Case Rep Oncol 2017 Sep-Dec;10(3):981-986. Epub 2017 Nov 6.

Department of Infectious Diseases, Kantonsspital Winterthur, Winterthur, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000481501DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5731155PMC
November 2017

Effects of nutrition and physical exercise intervention in palliative cancer patients: A randomized controlled trial.

Clin Nutr 2018 08 8;37(4):1202-1209. Epub 2017 Jun 8.

Kantonsspital Winterthur, Department of Medicine, CH-8401 Winterthur, Switzerland. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clnu.2017.05.027DOI Listing
August 2018

[Testicular Cancer: Diagnostics, Therapy and Follow Up].

Praxis (Bern 1994) 2016 May;105(11):643-8

1 Medizinische Onkologie, Kantonsspital Winterthur.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1024/1661-8157/a002364DOI Listing
May 2016

Final Results of a Prospective Evaluation of the Predictive Value of Interim Positron Emission Tomography in Patients With Diffuse Large B-Cell Lymphoma Treated With R-CHOP-14 (SAKK 38/07).

J Clin Oncol 2015 Aug 6;33(23):2523-9. Epub 2015 Jul 6.

Christoph Mamot and Mario Bargetzi, Cantonal Hospital Aarau, Aarau; Dirk Klingbiel, Christine Biaggi, and Corinne Rusterholz, Swiss Group for Clinical Cancer Research Coordinating Center; Thomas Pabst, Inselspital Bern, Bern; Felicitas Hitz and Christoph Driessen, Cantonal Hospital St. Gallen, St. Gallen; Christoph Renner, Hirslanden Zürich; Thomas Hany, Magnetic Resonance Imaging Roentgen Zürich; Andrei Samarin, University Hospital Zürich, Zürich; Ulrich Mey, Cantonal Hospital Graubuenden, Chur; Miklos Pless, Cantonal Hospital Winterthur, Winterthur; Fatime Krasniqi and Stephan Dirnhofer, University Hospital of Basel, Basel; Emanuele Zucca, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland; and Federica Gigli and Giovanni Martinelli, European Institute of Oncology Milan, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.58.9846DOI Listing
August 2015

Early treatment response in non-small cell lung cancer patients using diffusion-weighted imaging and functional diffusion maps--a feasibility study.

PLoS One 2014 7;9(10):e108052. Epub 2014 Oct 7.

Institute of Radiology and Nuclear Medicine, Clinical Research Unit, Hirslanden Hospital St. Anna, Lucerne, Switzerland; Department of Radiology, Paracelsus Medical University Salzburg, Salzburg, Austria.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0108052PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4188818PMC
June 2015

PET-Negative Gastrointestinal Stromal Tumors.

Case Rep Oncol 2013 5;6(3):508-13. Epub 2013 Oct 5.

Department of Oncology, Kantonsspital Winterthur, Winterthur, Chur, Switzerland.

View Article

Download full-text PDF

Source
https://www.karger.com/Article/FullText/355432
Publisher Site
http://dx.doi.org/10.1159/000355432DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3884209PMC
January 2014

A phase I/II trial of Tumor Treating Fields (TTFields) therapy in combination with pemetrexed for advanced non-small cell lung cancer.

Lung Cancer 2013 Sep 23;81(3):445-450. Epub 2013 Jul 23.

Medical Oncology, Cantonal Hospital Fribourg, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2013.06.025DOI Listing
September 2013

Analysis of the EGFR mutation status in head and neck squamous cell carcinoma before treatment with Gefitinib.

Onkologie 2013 18;36(4):161-6. Epub 2013 Mar 18.

Kopf-Hals-Tumor-Zentrum, Universitätsspital Basel, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000349941DOI Listing
September 2013

Multidisciplinary care in patients with prostate cancer: room for improvement.

Support Care Cancer 2013 Aug 26;21(8):2327-33. Epub 2013 Mar 26.

Department of Urology, Kantonsspital Graubünden, Chur, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00520-013-1791-xDOI Listing
August 2013

EGFR IHC score for selection of cetuximab treatment: Ready for clinical practice?

Transl Lung Cancer Res 2012 Jun;1(2):145-6

Kantonsspital Winterthur, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3978/j.issn.2218-6751.2012.03.01DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4367568PMC
June 2012

Homonymous hemianopsia in a patient with Hodgkin's lymphoma in remission after BEACOPP chemotherapy.

J Clin Oncol 2012 Apr 5;30(12):e130-2. Epub 2012 Mar 5.

Kantonsspital Winterthur, Winterthur, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2011.39.9634DOI Listing
April 2012

Tumor treating fields: concept, evidence and future.

Expert Opin Investig Drugs 2011 Aug 9;20(8):1099-106. Epub 2011 May 9.

Medical Oncology, Department of Internal Medicine, and Tumor Center, Kantonsspital Winterthur, Brauerstrasse, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/13543784.2011.583236DOI Listing
August 2011

Trimodality therapy for locally advanced non-small-cell lung cancer: a curative approach.

J Clin Oncol 2011 Feb 4;29(5):e118-9; author reply e120. Epub 2011 Jan 4.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2010.30.1143DOI Listing
February 2011

Acute Fatal Liver Toxicity under Erlotinib.

Case Rep Oncol 2010 Jun 8;3(2):182-188. Epub 2010 Jun 8.

Division of Medical Oncology, Department of Internal Medicine, Winterthur, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000315366DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2919997PMC
June 2010

Dose reduction of epoetin-alpha in the prevention of chemotherapy-induced anaemia.

Support Care Cancer 2010 Dec 17;18(12):1515-20. Epub 2009 Nov 17.

Centre Pluridisciplinaire d'Oncologie, University Hospital-CHUV BH06, Rue du Bugnon 46, 1011, Lausanne, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00520-009-0773-5DOI Listing
December 2010

Outcome of treated advanced non-small cell lung cancer with and without central airway obstruction.

Chest 2006 Dec;130(6):1803-7

Pulmonary Medicine, University Hospital Basel, Petersgraben 4, CH-4031 Basel, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1378/chest.130.6.1803DOI Listing
December 2006

A phase II, open-label study of gefitinib (IRESSA) in patients with locally advanced, metastatic, or relapsed renal-cell carcinoma.

Cancer Chemother Pharmacol 2006 Apr 29;57(4):533-9. Epub 2005 Jul 29.

Clinic and Policlinic of Oncology, University Hospital, Zurich, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-005-0070-zDOI Listing
April 2006

Significant progress in palliative treatment of non-small cell lung cancer in the past decade.

Chest 2005 Mar;127(3):738-47

Department of Medical Oncology, University Hospital of Basel, Petersgraben 4, CH-4031 Basel, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1378/chest.127.3.738DOI Listing
March 2005

Targeted radiotherapy for small cell lung cancer using 90Yttrium-DOTATOC, an Yttrium-labelled somatostatin analogue: a pilot trial.

Lung Cancer 2004 Sep;45(3):365-71

Division of Medical Oncology, University Hospital Basel, Petersgraben 4, CH-4031 Basel, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2004.02.020DOI Listing
September 2004

Tumor response and clinical benefit in neuroendocrine tumors after 7.4 GBq (90)Y-DOTATOC.

J Nucl Med 2002 May;43(5):610-6

PET Center, Institute of Nuclear Medicine, University Hospital, University of Basel, Basel, Switzerland.

View Article

Download full-text PDF

Source
May 2002